UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON D. C. 20549

                                  FORM 10-QSB/A

(Mark One)

[X] Quarterly report pursuant to Section 13 or 15(d) of the Securities and
Exchange Act of 1934 for the quarterly period ended June 30, 2004.

[ ] Transition report pursuant to Section 13 or 15(d) of the Exchange Act for
    the transition period from _______________ to _______________ .

                        Commission File Number: 000-50746

                            Cord Blood America, Inc.
                             -----------------------
               (Exact name of registrant as specified in charter)

           Florida                                      65-1078768
           -------                                      ----------
(State or other jurisdiction of             (I.R.S. Employer Identification No.)
 incorporation or organization)

                      10940 Wilshire Boulevard, Sixth Floor
                          Los Angeles, California 90024
                          -----------------------------
                    (Address of principal executive offices)

                                 (310) 443-4153
                                 --------------
              (Registrant's Telephone Number, including Area Code)

Check whether the registrant: (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements for the past
90 days. YES [X] NO [ ]

State the number of shares outstanding of each of the issuer's classes of common
equity, as of August 13, 2004: 25,317,200 shares of common stock, par value
$.0001 per share

Transitional Small Business Disclosure Format:  YES [ ]  NO [X]

<PAGE>

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

         (a)      Exhibits

         The following exhibits are filed as part of this Form 10-QSB.

Exhibit
Number   Description

2.0      Exchange Agreement dated as of March 31, 2004 by and between Cord Blood
         America, Inc. and certain shareholders of Cord Partners, Inc.*

3.0      Amended and Restated Articles of Incorporation of Cord Blood America,
         Inc.*

3.1      Amended and Restated Bylaws of Cord Blood America, Inc.*

4.0      Form of Common Stock Share Certificate of Cord Blood America, Inc.*

10.0     Patent License Agreement dated as of January 1, 2004 between PharmaStem
         Therapeutics, Inc. and Cord Partners, Inc.**

10.1     Service Agreement dated as of February 15, 2004 by and between Bergen
         Community Regional Blood Center and Cord Partners, Inc.**

10.2     Web Development and Maintenance Agreement dated March 18, 2004 by and
         between Gecko Media, Inc. and Cord Partners, Inc.*

10.3     Employment Agreement dated April 29, 2004 by and between Cord Blood
         America, Inc. and Matthew L. Schissler*

10.4     Employment Agreement dated April 29, 2004 by and between Cord Blood
         America, Inc. and Stephanie A. Schissler*

10.5     Stock Option Agreement dated April 29, 2004 by and between Cord Blood
         America, Inc. and Matthew L. Schissler*


<PAGE>

10.6     Stock Option Agreement dated April 29, 2004 by and between Cord Blood
         America, Inc. and Stephanie A. Schissler*

10.7     Stock Option Agreement dated April 29, 2004 by and between Cord Blood
         America, Inc. and Joseph R. Vicente*

10.8     Stock Option Agreement dated April 29, 2004 by and between Cord Blood
         America, Inc. and Stephen Weir*

10.9     Stock Option Agreement dated April 29, 2004 by and between Cord Blood
         America, Inc. and Gecko Media, Inc.*

10.10    License Agreement by and between Cord Partners, Inc. and Premier Office
         Centers, LLC**

10.11    Purchase and Sale of Future Receivables Agreement between Advanceme,
         Inc. and Cord Partners, Inc.**

10.12    Promissory Note dated August 12, 2004 made by Cord Blood America, Inc.
         to the order of Thomas R. Walkey**

21.0     Subsidiaries of the Registrant*

31.0     Certification of Cord Blood America, Inc. Chief Executive Officer,
         Matthew L. Schissler, pursuant to Section 302 of the Sarbanes-Oxley Act
         of 2002.

31.1     Certification of Cord Blood America, Inc. Principal Financial Officer,
         Sandra D. Smith, pursuant to Section 302 of the Sarbanes-Oxley Act of
         2002.

32.0     Certification of Cord Blood America, Inc. Chief Executive Officer,
         Matthew L. Schissler, pursuant to Section 906 of the Sarbanes-Oxley Act
         of 2002.

32.1     Certification of Cord Blood America, Inc. Chief Financial Officer,
         Sandra D. Smith, pursuant to Section 906 of the Sarbanes-Oxley Act of
         2002.

----------
*  Filed as an exhibit to Registration Statement on Form 10-SB filed on
   May 6, 2004.

** Filed as an exhibit to Amendment Number 1 to Registration Statement on
   Form 10-SB filed on August 23, 2004.

         (b) Reports on Form 8-K.

         No reports on Form 8-K were filed with the SEC during the period
         covered by this report.


<PAGE>

                                   SIGNATURES

         In accordance with Section 13 or 15(d) of the Securities Exchange Act
of 1934, the registrant has caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

                                      CORD BLOOD AMERICA, INC.




Date: August 23, 2004                 By:  /s/ Matthew L. Schissler
                                           ------------------------------------
                                           Matthew L. Schissler,
                                           Chairman and Chief Executive Officer
                                           (Principal Executive Officer)


                                      By:  /s/ Sandra D. Smith
                                           ------------------------------------
                                           Sandra D. Smith,
                                           Chief Financial Officer
                                           (Principal Financial and
                                           Accounting Officer)